Cite
HARVARD Citation
Velmurugan, B. et al. (2021). Dehydrocrenatidine inhibits head and neck cancer cells invasion and migration by modulating JNK1/2 and ERK1/2 pathway and decreases MMP‐2 expression. Environmental toxicology. 36 (9), pp. 1848-1856. [Online].